GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sectra SECT B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

315.60

-3.66%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2026

Revenue

SEK 3.54bn

FY2017FY2026

Net income

SEK 563.8m

FY2017FY2026

Free cash flow

SEK 1.01bn

FY2017FY2026

Shareholders' equity

SEK 2.14bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueSEK 3.54bnSEK 3.24bnSEK 2.96bnSEK 2.35bnSEK 1.95bnSEK 1.63bnSEK 1.66bnSEK 1.41bnSEK 1.27bnSEK 1.14bn
Research and developmentSEK 51.6mSEK 46.8mSEK 39.1mSEK 34.8mSEK 32.2mSEK 31.9mSEK 205.5mSEK 172.2mSEK 158.1mSEK 134.7m
Operating incomeSEK 662.8mSEK 496.6mSEK 518.5mSEK 455.7mSEK 383.4mSEK 350.1mSEK 295.3mSEK 235.5mSEK 239.1mSEK 200.4m
Net incomeSEK 563.8mSEK 563.4mSEK 428.4mSEK 375.0mSEK 314.8mSEK 275.5mSEK 237.4mSEK 199.0mSEK 198.3mSEK 152.8m
Diluted earnings per share3.102.922.221.951.631.431.231.031.030.79

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsSEK 4.47bnSEK 3.76bnSEK 3.21bnSEK 2.74bnSEK 2.19bnSEK 1.65bnSEK 1.51bnSEK 1.31bnSEK 1.23bnSEK 1.16bn
Cash and short-term investmentsSEK 1.81bnSEK 1.34bnSEK 804.6mSEK 945.2mSEK 808.8mSEK 454.9mSEK 345.3mSEK 331.9mSEK 282.3mSEK 273.2m
Total liabilitiesSEK 2.34bnSEK 1.84bnSEK 1.64bnSEK 1.44bnSEK 1.11bnSEK 756.3mSEK 694.6mSEK 586.9mSEK 628.4mSEK 607.9m
DebtSEK 76.5mSEK 87.5mSEK 31.8mSEK 82.3mSEK 62.6mSEK 73.5mSEK 87.4mSEK 31.5mSEK 28.1mSEK 77.6m
Shareholders' equitySEK 2.14bnSEK 1.92bnSEK 1.57bnSEK 1.30bnSEK 1.08bnSEK 895.6mSEK 817.2mSEK 727.9mSEK 606.0mSEK 554.5m
Shares outstanding182m193m193m193m193m193m193m193m193m192m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsSEK 1.10bnSEK 922.4mSEK 326.3mSEK 440.5mSEK 616.9mSEK 372.2mSEK 296.3mSEK 250.7mSEK 222.7mSEK 235.2m
Capital spending−SEK 85.5m−SEK 110.0m−SEK 250.7m−SEK 92.8m−SEK 74.4m−SEK 67.7m−SEK 77.7m−SEK 34.9m−SEK 53.6m−SEK 59.6m
Free cash flowSEK 1.01bnSEK 812.4mSEK 75.6mSEK 347.7mSEK 542.5mSEK 304.5mSEK 218.5mSEK 215.8mSEK 169.1mSEK 175.6m
Dividends paid——−SEK 211.9m−SEK 192.7m−SEK 173.4m—————

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
RevenueSEK 963.0mSEK 1.03bnSEK 892.0mSEK 850.6mSEK 765.9mSEK 914.1mSEK 848.4mSEK 753.5m
Operating incomeSEK 191.1mSEK 199.0mSEK 191.6mSEK 188.6mSEK 118.8mSEK 198.9mSEK 314.7mSEK 109.6m
Net incomeSEK 158.0mSEK 157.5mSEK 155.1mSEK 148.4mSEK 102.8mSEK 131.2mSEK 264.0mSEK 87.8m
Diluted earnings per share0.870.870.850.770.530.681.370.46
Cash from operationsSEK 2.0mSEK 519.0mSEK 418.0mSEK 41.0mSEK 118.0mSEK 222.0mSEK 580.0mSEK 176.0m
Capital spending−SEK 54.0m−SEK 38.0m−SEK 29.0m−SEK 9.0m−SEK 31.0m−SEK 1.0m−SEK 38.0m−SEK 27.0m
Free cash flow−SEK 52.0mSEK 481.0mSEK 389.0mSEK 32.0mSEK 87.0mSEK 221.0mSEK 542.0mSEK 149.0m
Total assetsSEK 4.49bnSEK 4.47bnSEK 4.05bnSEK 3.50bnSEK 3.76bnSEK 3.76bnSEK 3.88bnSEK 3.19bn
Cash and short-term investmentsSEK 1.75bnSEK 1.81bnSEK 1.35bnSEK 1.02bnSEK 1.43bnSEK 1.34bnSEK 1.16bnSEK 625.8m
DebtSEK 31.8mSEK 21.0mSEK 109.5mSEK 95.1mSEK 96.7mSEK 87.5mSEK 88.5mSEK 91.9m
Shareholders' equitySEK 2.32bnSEK 2.14bnSEK 1.93bnSEK 1.79bnSEK 2.05bnSEK 1.92bnSEK 1.81bnSEK 1.53bn

Financial ratios

Data as of 18 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin18.7%15.3%17.5%19.4%19.7%21.4%
Net margin15.9%17.4%14.5%16.0%16.2%16.9%
Return on equity26.4%29.4%27.3%28.9%29.1%30.8%
Return on assets12.6%15.0%13.3%13.7%14.4%16.7%
Free cash flow yield2.2%1.8%1.0%0.9%1.2%0.8%
Revenue growth9.3%9.3%26.1%20.6%19.4%-1.7%
Earnings growth0.1%31.5%14.2%19.1%14.3%16.1%
Current ratio1.61x1.74x1.59x1.62x1.57x1.67x
Debt to equity0.01x0.01x0.01x0.02x0.02x0.03x
Equity ratio47.8%51.0%48.9%47.4%49.3%54.2%
Interest coverage88.18x115.28x157.88x220.98x246.55x189.85x
R&D as a share of sales1.5%1.4%1.3%1.5%1.7%2.0%
Buybacks as a share of market value5.5%-0.0%0.0%0.0%0.0%-0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.6%16.8%12.7%
Operating income13.3%13.6%14.9%
Net income14.6%15.4%16.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin17.1%17.6%18.3%18.0%
Net margin16.6%16.0%16.1%15.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings105.585.8124.492.691.1140.0119.175.736.743.3
Price to sales16.814.918.014.814.723.617.010.75.85.8

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 10 Sept 2025.

FY2026FY2009FY2008FY2007FY2006FY2005FY2004FY2003
Paid in the year2.100.100.100.100.100.200.200.16
  • 2-to-1 reverse split · 7 Oct 2024
  • 5-for-1 split · 24 Sept 2021
  • 3-for-1 split · 11 Aug 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.